Identification by quantitative chromatin pattern analysis of patients at risk for recurrence of superficial transitional bladder carcinoma.

PURPOSE Based on the actual clinical outcomes of 132 fully documented patients with superficial transitional cell carcinoma of the bladder, we characterize the risk of recurrence and/or progression by computer assisted image microscopy applied to Feulgen stained nuclei. MATERIALS AND METHODS Each tumor was characterized by the conventional grading and staging systems as well as by cytometry generated variables describing nuclear DNA content, nuclear morphometry and chromatin patterns. These data were submitted to discriminant analysis to establish a model distinguishing between 2 groups of patients. Group 1 included cases with remission for more than 60 months and group 2 cases presented with recurrence with or without progression within 12 months of transurethral bladder resection. This latter model was then validated by Kaplan-Meyer analysis of the full data set. RESULTS As evidenced by Kaplan-Meier analysis, the discriminant factor generated by discriminant analysis of cytometry generated variables provided a cutoff value for distinguishing between low and high risks of recurrence (p <0.00001). In contrast, conventional grading and staging systems were not able to make such efficient distinction. CONCLUSIONS These 2 groups can be used as references with which new cases can be compared to prognosticate disease behavior independently of histopathological grading and/or clinical staging.

[1]  R. Hurst,et al.  Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue. , 1991, The Journal of urology.

[2]  C Decaestecker,et al.  THE USE OF THE DECISION TREE TECHNIQUE AND IMAGE CYTOMETRY TO CHARACTERIZE AGGRESSIVENESS IN WORLD HEALTH ORGANIZATION (WHO) GRADE II SUPERFICIAL TRANSITIONAL CELL CARCINOMAS OF THE BLADDER , 1996, The Journal of pathology.

[3]  C. Bouffioux Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group. , 1991, Scandinavian journal of urology and nephrology. Supplementum.

[4]  M Petein,et al.  Computer‐assisted chromatin texture characterization of Feulgen‐stained nuclei in a series of 331 transitional bladder cell carcinomas , 1994, The Journal of pathology.

[5]  E. Pesonen,et al.  Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. , 1991, The Journal of urology.

[6]  M. Tachibana,et al.  Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients. , 1991, The Journal of urology.

[7]  M Petein,et al.  Computerized morphonuclear cell image analyses of malignant disease in bladder tissues. , 1990, The Journal of urology.

[8]  M. Boon,et al.  Analysis of the performance of pathologists in the grading of bladder tumors. , 1983, Human pathology.

[9]  I. Hanham Cancer of the Kidney and Urinary Tract , 1982 .

[10]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[11]  B. Turner International Union Against Cancer (UICC) , 1999 .

[12]  M Petein,et al.  The use of digital image analysis of chromatin texture in feulgen‐stained nuclei to predict recurrence of low grade superficial transitional cell carcinoma of the bladder , 1995, Cancer.

[13]  S. Johansson,et al.  The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. , 1995, The Journal of urology.

[14]  R. Kiss,et al.  Characterization of factors in routine laboratory protocols that significantly influence the Feulgen reaction. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  R. Sylvester,et al.  Factors affecting recurrence and progression in superficial bladder tumours. , 1995, European journal of cancer.

[16]  O. Dalesio,et al.  Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. , 1983, The Journal of urology.

[17]  R. Sylvester,et al.  Prognostic factors in superficial bladder tumors , 1992 .

[18]  L. Wheeless,et al.  Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. , 1993, Cytometry.